3,3′,5′-Triiodo-L-thyronine

<strong>3,3′,5′-Triiodo-L-thyronine</strong>_x000D_ <strong>Catalog number:</strong> B2010546_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 650.97 g/mol_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> molecular tool for various research experiments_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> Reverse T3, rT(3)_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Grymuła K, Paczkowska E, Dziedziejko V, Baśkiewicz-Masiuk M, Kawa M, Baumert_x000D_ B, Celewicz Z, Gawrych E, Machaliński B. The influence of 3,3',5-triiodo-L-_x000D_ thyronine on human haematopoiesis. Cell Prolif. 2007 Jun;40(3):302-15._x000D_ _x000D_ 2: Cahnmann HJ, Gonçalves E, Ito Y, Fales HM, Sokoloski EA. Synthesis and_x000D_ characterization of N-bromoacetyl-3,3',5-triiodo-L-thyronine. J Chromatogr. 1991_x000D_ Jan 18;538(1):165-75._x000D_ _x000D_ 3: Kitagawa S, Obata T, Hasumura S, Pastan I, Cheng SY. A cellular_x000D_ 3,3',5-triiodo-L-thyronine binding protein from a human carcinoma cell line._x000D_ Purification and characterization. J Biol Chem. 1987 Mar 15;262(8):3903-8._x000D_ _x000D_ 4: Cheng SY, Ransom SC, McPhie P, Bhat MK, Mixson AJ, Wintraub BD. Analysis of_x000D_ the binding of 3,3',5-triiodo-L-thyronine and its analogues to mutant human beta_x000D_ 1 thyroid hormone receptors: a model of the hormone binding site. Biochemistry._x000D_ 1994 Apr 12;33(14):4319-26._x000D_ _x000D_ 5: Groeneweg S, Peeters RP, Visser TJ, Visser WE. Triiodothyroacetic acid in_x000D_ health and disease. J Endocrinol. 2017 Aug;234(2):R99-R121._x000D_ _x000D_ 6: Hoffenberg R. Triiodothyronine. Clin Endocrinol (Oxf). 1973 Jan;2(1):75-87._x000D_ _x000D_ 7: Richards K, Rijntjes E, Rathmann D, Köhrle J. Avoiding the pitfalls when_x000D_ quantifying thyroid hormones and their metabolites using mass spectrometric_x000D_ methods: The role of quality assurance. Mol Cell Endocrinol. 2017 Dec_x000D_ 15;458:44-56._x000D_ _x000D_ 8: PITTMAN JA, BROWN RW, REGISTER HB Jr. Biological activity of 3,3',5'-triiodo-_x000D_ DL-thyronine. Endocrinology. 1962 Jan;70:79-83._x000D_ _x000D_ 9: Sar P, Rath B, Subudhi U, Chainy GB, Supakar PC. Alterations in expression of_x000D_ senescence marker protein-30 gene by 3,3',5-triiodo-L-thyronine (T3). Mol Cell_x000D_ Biochem. 2007 Sep;303(1-2):239-42._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/29125479/">10: Rodríguez-Molinero A, Hercbergs A, Sarrias M, Yuste A. Plasma_x000D_ 3,3',5-Triiodo-L-thyronine [T3] level mirrors changes in tumor markers in two_x000D_ cases of metastatic cancer of the breast and pancreas treated with exogenous_x000D_ L-T3. Cancer Biomark. 2018 Feb 6;21(2):433-438. </a>_x000D_ _x000D_ <strong>Products Related to 3,3′,5′-Triiodo-L-thyronine</strong><a href="https://moleculardepot.com/product-category/Chemicals/">: Chemicals</a>